InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Borges Luis. Director active across 2 companies, notably Century Therapeutics, Inc.. In total, 4 disclosures have been recorded. Activity tracked since 2 February 2023. The latest transaction was filed on 1 April 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Borges Luis is a declarant linked to Century Therapeutics, Inc. and Metagenomi, Inc., where he is Chief Scientific Officer. He has 4 filings in total, and across the 4 sampled recent filings, the modal transaction nature is Attribution, with a range from 2023-02-06 to 2024-04-03.